Breakthroughs in nanoparticle diabetes therapies, including oral insulin and smart glucose-responsive systems, could revolutionize treatment paradigms by 2027-2030. Recent advances in nanoparticle-bas...
Examining ashwagandha, guggul and bitter melon’s pharmacological effects on metabolic disorders, with clinical evidence and expert perspectives on integration with Western medicine. As clinical ...
Emerging research reveals how gut bacteria influence obesity through probiotics, prebiotics, and fecal transplants, with new treatments showing promising results in clinical trials. Cutting-edge studi...
Recent studies reveal intermittent fasting effectively lowers blood pressure in obese adults but may harm elderly patients with severe hypertension, requiring personalized approaches. Emerging researc...
Recent studies reveal turmeric’s potential in diabetes management, with curcumin improving glycemic control and reducing inflammation, though bioavailability remains a challenge. Turmeric’...
Exploring how blockchain technology can enhance quality tracking of Curcumae kwangsiensis radix, combining traditional spectrum-effect research with modern traceability systems. Recent advancements in...
Chitosan-polyvinyl alcohol bionanocomposites with turmeric oil show 80% efficacy against Pythium myriotylum, presenting a sustainable alternative to banned synthetic fungicides. New bionanocomposites ...
A new UCSF clinical trial explores time-restricted eating’s neuroprotective potential in Huntington’s disease, building on recent mitochondrial function research. Researchers at UCSF are t...
New research reveals prenatal PFAS exposure disrupts maternal beta cell function, increasing gestational diabetes risk by up to 40%, with actionable prevention strategies. Groundbreaking study shows &...
The first pilot study on intravenous BPC-157 demonstrates safety while revealing ethical dilemmas as off-label use surges in sports medicine. Groundbreaking human data on intravenous BPC-157 emerges a...
